IMPRS-ML | International Max Planck Research School for Molecules of Life

What IMPRS-ML | International Max Planck Research School for Molecules of Life does

IMPRS-ML (International Max Planck Research School for Molecules of Life) is a structured doctoral training program operated under the Max Planck Society at the Life Science Campus Martinsried-Großhadern in Munich, Germany. It recruits international early-career researchers for fully funded PhD positions across six molecular life science disciplines: biochemistry, structural biology, biophysics, cell biology, systems biology, and computational biology. The program is hosted at the Max Planck Institute of Biochemistry (MPIB), in cooperation with the Max Planck Institute for Biological Intelligence (MPI-BI), Ludwig Maximilian University of Munich (LMU), and the Technical University of Munich (TUM), and benefits from co-location with the LMU Biocenter, LMU Biomedical Center, Gene Center, and the Biotechnology Innovation and Start-Up Centre (IZB) which hosts over 50 biotech startups. Together, MPIB and MPI-BI employ over 1,000 staff, making the campus one of the largest Max Planck sites globally.

The program's model is public-sector academic training rather than commercial product delivery. It does not charge tuition, does not sell products or services, and generates no commercial revenue. Funding flows in the form of research grants from the Max Planck Society, the German Research Foundation (DFG), and EU research programs, which underwrite PhD stipends and employment contracts. Applicants access the program exclusively through an annual online application cycle (the 2026/2027 round opens 25 August 2026 and closes 7 October 2026), culminating in panel interviews and an in-person matchmaking visit to Munich; travel and accommodation for invited candidates are reimbursed by the program. Recruitment and community engagement leverage the Max Planck PhDnet, faculty presence at scientific conferences, and three social channels (Instagram, LinkedIn, Bluesky), supported by an annual retreat, Future Skills workshops, and a Biotech & Pharmacy Career Day. Governance is partly provided by a PhD Association (founded 2001) that elects representatives to the IMPRS-ML Board and to institute- and MPG-wide forums.

IMPRS-ML's measured output is research and publication rather than commercial artifacts: the program's publications page lists 125+ journal articles spanning 2021–2026 in journals including Nature, Cell, Molecular Cell, Nature Communications, and PNAS. Faculty are embedded in multiple Excellence Clusters (CIPSM, SyNergy, MCN, BCCN, CeNS), and the program's stated differentiation rests on interdisciplinary integration of six disciplines on a single campus, structured curriculum alongside independent research, shared core facilities (including cryo-electron tomography, mass spectrometry/proteomics, and super-resolution DNA-PAINT microscopy), and the prestige of Max Planck Society and partner-university affiliation.

Name

IMPRS-ML | International Max Planck Research School for Molecules of Life

Legal name

International Max Planck Research School for Molecules of Life

Website

https://imprs-ml.mpg.de

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

The International Max Planck Research School for Molecules of Life (IMPRS-ML) is a publicly funded Max Planck Society doctoral training program in Munich that recruits international PhD candidates for fully funded research positions across six molecular life science disciplines, partnering with MPIB, MPI-BI, LMU, and TUM.

Ownership category

akta.pro rank

Headquarters

HQ city

Munich/Martinsried

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Public Research Funding: IMPRS-ML is funded through the Max Planck Society and partner universities (MPIB, LMU, TUM) as a publicly funded doctoral training program. It does not charge tuition or generate commercial revenue. PhD researchers receive stipends or salary contracts funded by the Max Planck Society, German Research Foundation (DFG), and EU research grants.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

IMPRS-ML is a structured doctoral (PhD) training program operated under the Max Planck Society, training early-career researchers in biochemistry, structural biology, biophysics, cell biology, systems biology, and computational biology. The program is hosted at the Max Planck Institute of Biochemistry (MPIB) on the Life Science Campus Martinsried-Großhadern in Munich, with affiliated faculty from LMU Munich and TUM. PhD positions are fully funded (no tuition) and selected through an annual application cycle.

Product overview

IMPRS-ML (International Max Planck Research School for Molecules of Life) is a structured PhD training program operated by the Max Planck Society, offering doctoral research positions in biochemistry, structural biology, biophysics, cell biology, systems biology, and computational biology. The program provides a coordinated curriculum, access to research groups at MPIB, LMU, and TUM, PhD student representation, career development events, and annual retreats. This is an educational/academic training program, not a commercial product or software offering.

Differentiator

Problem solved

Functional benefit

Products and services

• IMPRS-ML Structured PhD Program in Molecular Life Sciences

Quantifiable outcome

• 125+ journal articles published by PhD students and faculty, spanning 2021–2026, in leading journals including Nature, Cell, Molecular Cell, Nature Communications, and PNAS
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Twelve partnerships are on record, tiered core and minor.

• Max Planck Institute of Biochemistry (MPIB)coreStrategic or Co-development PartnerIMPRS-ML is hosted at the Max Planck Institute of Biochemistry (MPIB) on the Life Science Campus Martinsried-Großhadern in Munich. MPIB is one of the largest biological and medical research institutions of the Max Planck Society and serves as the primary institutional host for the IMPRS-ML Coordination Office and the majority of its faculty research groups. The PhD Association works closely with the MPIB PostDoc Association.
• Ludwig Maximilian University of Munich (LMU)coreStrategic or Co-development PartnerLMU Munich is a key partner university of IMPRS-ML. The LMU Faculty of Chemistry and Pharmacy, Biocenter, and Biomedical Center (BMC) of LMU are located in the immediate vicinity of the MPIB campus. LMU faculty members participate as supervisors and mentors in the IMPRS-ML program, and LMU PhD students can be members of the IMPRS-ML community.
• Technical University of Munich (TUM)coreStrategic or Co-development PartnerTUM is a partner university of IMPRS-ML. PhD students affiliated with TUM can be members of the IMPRS-ML community, and TUM faculty members participate as supervisors in the program.
• Max Planck Institute for Biological Intelligence (MPI-BI)coreStrategic or Co-development PartnerThe Max Planck Institute for Biological Intelligence (MPI-BI) has been an integral part of the Martinsried campus since 1984, located in the immediate vicinity of MPIB. With over 1000 employees combined at MPIB and MPI-BI, the campus is one of the largest Max Planck sites in the world. MPI-BI faculty members participate in the IMPRS-ML program.
• Innovation and Start-up Centre for Biotechnology (IZB)minorOthersThe Innovation and Start-up Centre for Biotechnology (IZB) is located on the Life Science Campus Martinsried-Großhadern. On 25,000 m², the IZB hosts over 50 biotech start-ups. Several successful companies have started as spin-offs of the Max Planck Institutes. The IZB is part of the broader campus ecosystem accessible to IMPRS-ML PhD students.
• CIPSM (Center for Integrated Protein Science Munich)coreStrategic or Co-development PartnerCIPSM is a German Excellence Cluster that brings together scientists from the LMU and TUM in the field of integrated protein science. IMPRS-ML faculty members are heavily engaged in CIPSM, which is one of the key research networks on the campus.
• SyNergy (Munich Cluster for Systems Neurology)coreStrategic or Co-development PartnerSyNergy is a German Excellence Cluster focused on systems neurology. IMPRS-ML faculty members participate in SyNergy, which contributes substantially to scientific cooperation and collaboration on the Martinsried-Großhadern campus.
• MCN (Munich Center for Neurosciences)minorStrategic or Co-development PartnerMCN is a Munich research network that brings together scientists from various research areas to foster interdisciplinary research at the highest level. IMPRS-ML faculty members are engaged in MCN.
• BCCN (Bernstein Center for Computational Neuroscience)minorStrategic or Co-development PartnerBCCN (Bernstein Center for Computational Neuroscience) is one of the networks that brings together scientists from various research areas to foster interdisciplinary research on the campus. IMPRS-ML faculty members participate in BCCN.
• CeNS (Center for NanoScience)minorStrategic or Co-development PartnerCeNS (Center for NanoScience) is a Munich-based research network that fosters interdisciplinary nanoscience research. IMPRS-ML faculty members participate in CeNS.
• Max Planck PhDnetcoreStrategic or Co-development PartnerThe Max Planck PhDnet is the official network of all Max Planck Society PhD students. It manages a convenient web portal that facilitates communication between students, programs, and the society. IMPRS-ML PhD students are connected to the Max Planck PhDnet, which provides peer networking, shared resources, and career planning support across all Max Planck Institutes.
• MPIB PostDoc AssociationminorStrategic or Co-development PartnerThe PhD Association of IMPRS-ML works closely with the MPIB PostDoc Association, facilitating cross-career-stage networking and community building at the institute level.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Wellcome Trust PhD Programmes: Wellcome-funded PhD programmes across UK institutions (e.g., at Cambridge, UCL, Edinburgh) are fully funded, research-focused doctoral training tracks in life sciences with international intake — directly comparable in funding model, selectivity, and scientific scope to IMPRS-ML.
• Helmholtz International Doctoral Schools: Helmholtz Association doctoral training programs (e.g., at Helmholtz Munich, DKFZ) are Germany's parallel publicly funded international PhD schools in life sciences, sharing applicant pools and faculty with Max Planck schools.
• Other International Max Planck Research Schools (IMPRS network): Sister programs under the same Max Planck Society umbrella (e.g., IMPRS-LM, IMPRS-MCB, IMPRS-IDI) offer the same model — fully funded, interdisciplinary graduate training in life and related sciences — and compete directly with IMPRS-ML for applicants and faculty.
• Harvard Program in Biological and Biomedical Sciences (BBS): Harvard BBS is a fully funded umbrella PhD program in molecular, cellular, and systems biology that integrates multiple Harvard departments and hospitals — comparable in interdisciplinary structure, prestige, and global recruitment to IMPRS-ML.
• EMBL International PhD Programme: The European Molecular Biology Laboratory's predoctoral programme is the closest peer to IMPRS-ML — a fully funded, highly selective international PhD training program in molecular life sciences spanning multiple EMBL sites in Europe, with structured curriculum and rotation-based admissions.
• Pasteur Institute PhD Programme: The Institut Pasteur's international PhD program offers fully funded, English-language doctoral training in molecular biology, microbiology, and immunology — a structurally similar publicly funded research training program competing with IMPRS-ML for European and global applicants.
• ETH Zurich Department of Biology PhD Programs: ETH Zurich's biology, biochemistry, and biophysics doctoral programs are fully funded research training tracks with strong interdisciplinary orientation, comparable to IMPRS-ML in faculty profile, funding model (public), and applicant competitiveness.
• MRC Laboratory of Molecular Biology (LMB) PhD Programme: LMB's PhD programme at Cambridge is a globally competitive, fully funded doctoral training program in molecular biology and structural biology — directly comparable to IMPRS-ML in research focus and elite applicant targeting.

Broad incumbents

• Marie Skłodowska-Curie Doctoral Networks (EU MSCA-DN): EU-funded MSCA Doctoral Networks are pan-European, multi-institutional PhD training consortia offering fully funded positions in life sciences. They overlap with IMPRS-ML in applicant pool, research areas, and funding source, providing an alternative funded pathway for similar candidates.

Emerging players

• Boehringer Ingelheim Fonds (BIF) PhD Fellowships: BIF is a private non-profit foundation that funds outstanding PhD candidates in biomedical research globally. While not a university-based program, BIF competes with IMPRS-ML for top-tier international life-science PhD applicants by offering generous personal fellowships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xbsky.app/profile/imprs-ml.mpg.de
• LinkedInlinkedin.com/school/imprs-ml
• Instagraminstagram.com/imprs_ml

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IMPRS-ML | International Max Planck Research School for Molecules of Life